Rare diseases
Investigational molecules
Locations
Lilly Corporate Center, 46285-0001, United States
Morphic Therapeutic Inc. focuses its clinical research on inflammatory bowel disease, with studies centered on adults living with moderately to severely active Crohn’s disease and moderately to severely active ulcerative colitis. The sponsor’s trial portfolio is directed toward gastrointestinal inflammation and disease control in these chronic conditions.
Clinical activity spans multiple countries and collaborating research sites, reflecting an active development program in gastroenterology.
Morphic Therapeutic Inc. runs clinical trials in conditions such as Colitis ulcerative, Crohn's disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustria
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
